Human hepatocyte isolation and relationship of cell viability to early graft function.
Open Access
- 1 January 2003
- journal article
- Published by SAGE Publications in Cell Transplantation
- Vol. 12 (1) , 69-74
- https://doi.org/10.3727/000000003783985197
Abstract
Hepatocyte transplantation is emerging as an additional modality of treatment for patients with acute liver failure or liver-based metabolic disorders. The procedure requires isolation of high-quality hepatocytes from unused donor livers. Hepatocytes were isolated from 20 donor livers (11 right lobes, 3 left lateral segments, 6 whole livers) using a collagenase perfusion technique. Cell viability (median 56%, range 13–95%) and yield (median 1.4 × 109 cells, range 2.0 × 106–1.8 × 1010 cells) varied according to the tissue available. Fatty livers rejected for transplantation gave lower cell viability (median 45%, range 25–59%). There was a significant correlation between age of donor (median 21 years, range 7–66 years) and viability of isolated hepatocytes in vitro (r = −0.683, p = 0.001). The 13 segments of livers were from reduced/split grafts used for clinical transplantation in 9 children and 4 adults. There was no significant correlation between in vitro cell viability and clinical parameters including intensive care stay, serum aspartate aminotransferase, and international normalized ratio (in the first 7 days), and allograft rejection or other early posttransplant complications, in patients transplanted with the corresponding tissue.Keywords
This publication has 14 references indexed in Scilit:
- Auxiliary Liver Transplantation and Bioartificial BridgingProcedures in Treatment of Acute Liver FailureWorld Journal of Surgery, 2002
- Fatty Liver in Liver Transplantation and SurgerySeminars in Liver Disease, 2001
- Hepatic Progenitors and Strategies for Liver Cell TherapiesAnnals of the New York Academy of Sciences, 2001
- Cytokines in Alcoholic and Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2000
- The capability of isolated hepatocytes and liver slices of donor livers to predict graft function after liver transplantationLiver International, 2000
- Efficacy and current problems with a porcine hepatocyte-based bioartificial liver: light and shadeTransplantation Proceedings, 1999
- Auxiliary Partial Orthotopic Liver Transplantation for Crigler-Najjar Syndrome Type IAnnals of Surgery, 1999
- Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte TransplantationNew England Journal of Medicine, 1998
- In vivo demonstration of impaired microcirculation in steatotic human liver graftsLiver Transplantation and Surgery, 1998
- HEPATOCYTE TRANSPLANTATION AS A BRIDGE TO ORTHOTOPIC LIVER TRANSPLANTATION IN TERMINAL LIVER FAILURETransplantation, 1997